The Morning BriefThe Morning Brief
To make sense of the week’s hottest stories in business, economy, politics and markets, journalists from the Economic Times chat with reporters and in…A revolution is underway in cancer diagnosis. A gene-based test called next-generation sequencing can identify precise mutations in a patient’s DNA, which can then be treated with targeted therapies instead of painful chemotherapy. For an 80-year-old woman with stage 4 lung cancer, it meant walking again. For a 24-year-old with breast cancer, it meant a normal life. But since NGS tests can cost up to Rs 4 lakh, a unique collaboration called LuNGS Alliance is making it free for lung cancer patients across India — offering a glimpse of how medical breakthroughs can be made accessible and affordable for all.
Vikas Dandekar and Arijit Barman report. Anirban Chowdhury narrates for audio
Listen in.
In 1 playlist(s)
The Morning Brief
To make sense of the week’s hottest stories in business, economy, politics and markets, journalists …Social links
Follow podcast
Recent clips
WhatsApp Users’ New Identity Crisis
17:41
The Heat Dome Files: What Europe Can Learn From India
26:10
Tracxn Co-Founder on India’s Startup Paradox: More Money, Fewer Bets
14:31